Dr. Gabrail Nashat
Claim this profileGabrail Cancer Center Research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
5 reported clinical trials
15 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Stage III
2Lung Cancer
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Gabrail Nashat is currently running
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting0 awards Phase 2 & 3
Fuzuloparib + AA-P
for Prostate Cancer
This trial is testing whether a combination of Fuzuloparib and AA-P is better for treating advanced prostate cancer. The treatment aims to kill cancer cells by preventing them from fixing their damaged DNA and by reducing hormone levels that help the cancer grow. The study includes patients with and without specific DNA repair deficiencies.
Recruiting1 award Phase 37 criteria
More about Gabrail Nashat
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Gabrail Nashat has experience with
- Cemiplimab
- Fianlimab
- Cisplatin
- Paclitaxel
- Pemetrexed
- NovoTTF-100L(P)
Breakdown of trials Gabrail Nashat has run
Non-Small Cell Lung Cancer
Lung Cancer
Adenocarcinoma
Pancreatic Adenocarcinoma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gabrail Nashat specialize in?
Gabrail Nashat focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Gabrail Nashat currently recruiting for clinical trials?
Yes, Gabrail Nashat is currently recruiting for 4 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Gabrail Nashat has studied deeply?
Yes, Gabrail Nashat has studied treatments such as Cemiplimab, Fianlimab, Cisplatin.
What is the best way to schedule an appointment with Gabrail Nashat?
Apply for one of the trials that Gabrail Nashat is conducting.
What is the office address of Gabrail Nashat?
The office of Gabrail Nashat is located at: Gabrail Cancer Center Research, Canton, Ohio 44718 United States. This is the address for their practice at the Gabrail Cancer Center Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.